Is it time to revisit contraindications to organ donation from donors with a JAK-2 mutation? Safe use of a liver allograft from a donor with essential thrombocythaemia

Transplant International : Official Journal of the European Society for Organ Transplantation
Debashis HaldarM Thamara Pr Perera

Abstract

Transplantation can cure end-stage liver disease and hepatocellular carcinoma. However, the balance of organ demand and provision is heavily tipped to the detriment of patients. Patients awaiting transplantation rely on the greater use of marginal donors that may carry a risk to the recipient. UK authorities have decreed donor haematological malignancy an absolute contraindication. The authors describe the first report of a patient being safely transplanted with a liver from a donor who suffered from JAK2 V617F mutation-driven essential thrombocythaemia to a patient with a critical burden of hepatocellular carcinoma. A year after transplantation, the patient has neither evidence of acquisition of the donor's pathology, nor evidence of carcinoma recurrence. The case highlights the responsibility of the recipient team to maximize the use of organs by expert risk assessment. Dissemination of experience should inform future decisions, benefit patients and bolster utility in an era of growing waiting-list mortality.

References

Jan 2, 2008·Haematologica·Elisabetta AntonioliUNKNOWN Myeloproliferative Disorders Research Consortium (MPD-RC)
Jul 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tiziano BarbuiAyalew Tefferi
Aug 13, 2011·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Argirios E TsantesGeorgios Mantzios
Sep 15, 2012·Transplantation Proceedings·P FiaschettiW F Grigioni
Oct 23, 2013·Current Hematologic Malignancy Reports·Hans Michael Kvasnicka
Jun 28, 2014·American Journal of Hematology·Glen J TitmarshLesley A Anderson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.